Search - tctmd.com

Displaying 741 - 760 of 818

Sort: Relevancy | Date

Presentation TCT 2013

Synthesis of Clinical Trials with the Biomatrix Stent

Presenter: Stephan Windecker

October 28, 2013

Presentation TCT 2013

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Presenter: Clemens von Birgelen

October 28, 2013

Presentation TCT 2013

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Presenter: Lisette Okkels Jensen

October 28, 2013

Presentation TCT 2013

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

Presenter: Peter Smits

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

News Conference News TCT 2013

Efficacy of PFO Closure Still Undetermined

October 28, 2013

News Conference News TCT 2013

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

October 28, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Yes: Clinical Trials Wwll Show Fewer Early and Late Events!

Presenter: Didier Carri?

October 27, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2013

The BioMime Stent and Merit Clinical Trials

Presenter: Martin Leon

October 27, 2013

Presentation TCT 2013

Moving Forward: The Dawn of Patient-Centered Clinical Trials and Translational Tools

Presenter: Bray Patrick-Lake

October 27, 2013

Presentation TCT 2013

How to be a Key Enroller in Clinical Trials: Bringing Your Colleagues Together

Presenter: Nicholas Lembo

October 27, 2013

Presentation TCT 2013

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati

January 31, 2013

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

News Conference News TCT 2012

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

October 31, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

Advertisement

Synthesis of Clinical Trials with the Biomatrix Stent

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Memories of TCT 1988 and Beyond: Marvin L. Woodall

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Efficacy of PFO Closure Still Undetermined

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

Cre8, BioFreedom Polymer-Free DES Show Promise

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Yes: Clinical Trials Wwll Show Fewer Early and Late Events!

The Spectrum of Current and Future Renal Denervation Clinical Trials

The BioMime Stent and Merit Clinical Trials

Moving Forward: The Dawn of Patient-Centered Clinical Trials and Translational Tools

How to be a Key Enroller in Clinical Trials: Bringing Your Colleagues Together

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content